The weekly email
The quiet boom: how UK patients get prescribed
By
Good morning. It is Wednesday 17 June 2026, and this issue runs about 750 words, a 5-minute read. This issue: how UK patients get prescribed now, from fewer than 250 people in 2019 to tens of thousands today, why only a specialist can start it, a survey worth reading carefully, and a calm word on that driving headline. We end somewhere hopeful.
Several pieces this week described a UK medical cannabis ‘boom’, with access spreading through private clinics and telehealth. The growth is real. In 2019, fewer than 250 people in the UK had a prescription. Today the estimates run to roughly 60,000 to 80,000 active patients. That is a striking change in a few years, and it is worth understanding plainly, because the route is more reachable than most people think, and more limited than the word ‘boom’ suggests.
What this means for you: if you are considering it, the path to start is straightforward. You do not need a GP referral. You approach a private clinic directly, a specialist reviews your history, often by video from home, and if cannabis suits you when licensed options have not, your medicine is posted from a pharmacy. More than 99 percent of prescriptions are private, so plan for the cost, and see our What it costs hub before you begin.
The other side, fairly: a fast-growing private market carries risks. Around 20 to 25 specialist clinics operate, and some open and close quickly, which can disrupt continuity of care. There is no official government count of patients, so the headline numbers are estimates drawn from dispensing data and clinic figures, not a precise census. And ‘boom’ language can oversell a market that is still small next to the number of people who might benefit.
Where we land: access has genuinely opened up, and for people who were stuck for years, that is good news. But it is a private, paid, specialist route, not an NHS one. NHS prescribing stays rare, limited to a few conditions such as severe epilepsy and MS spasticity. Knowing that before you start is the difference between a clear decision and a costly surprise.
See the NHS guide to the legal route ↗
Sources: NHS and NHS England on the legal route. Patient-number estimates from the Cannabis Industry Council, an industry body, and NHSBSA dispensing data, mid-2026. No official government patient count exists. Not medical advice.
Plain English: ‘Specialist Register’
The term. People are often surprised that their own GP cannot start a cannabis prescription. The reason is the Specialist Register.
What it means. The General Medical Council keeps a Specialist Register, a list of doctors who have completed advanced training in a particular field, such as pain medicine, neurology or psychiatry. Since 2018, only a doctor on that register can decide to prescribe medical cannabis. A GP cannot start it, though they can refer you or share your records.
Why it matters to you. It explains the shape of the whole route. You begin with a private specialist, not your GP, which is why approaching a clinic yourself is normal and not a sign you are doing anything irregular. It is also a safeguard. The rule exists so that an experienced specialist, not a generalist, weighs whether cannabis suits you.
Glossary · Specialist Register: the GMC’s list of doctors with advanced training in a field. Only a doctor on it can start a medical cannabis prescription in the UK. One term decoded each week.
For the official picture, see the NHS page on medical cannabis. Not medical advice.
Also this week
▸ A survey, and a fair caution. A UK multi-clinic survey reported this week that most medical cannabis patients said their mental-health symptoms had improved. The same week, the charity Drug Science cautioned that combining poor-quality studies tells you little. Both can be true.
Why this matters: a patient survey records what people report, not what a medicine does. It cannot separate the medicine from hope, from attention, or from the relief of finally being taken seriously. That does not make patients wrong. It means a survey headline is a starting point for research, not proof. Read big claims, in either direction, with that in mind.
Sources: a UK multi-clinic patient survey, reported June 2026, and Drug Science ↗. Whether a medicine suits you is a clinical judgement, not a survey result. Not medical advice.
▸ Still seeing the driving-ban headline? A piece about prescription medicines that ‘trigger automatic driving bans’ went round again. The calm version stands. A prescription is not an automatic ban. If your cannabis is prescribed, taken as directed, and you are not impaired, a medical defence applies, though THC has a legal limit and impairment is a separate offence. Tell DVLA if your condition affects your driving.
Source: UK drug-driving law and the Road Traffic Act 1988. Not legal advice
One good thing
For years, nobody really knew who the UK’s cannabis patients were. This year changed that. The largest UK patient survey since legalisation has been run, and new research has estimated patient numbers from NHS dispensing data for the first time. Being counted matters. It is how patients start to be taken seriously, in clinics, in research, and in time, in policy.
Source: Cannabis Industry Council research and UK patient survey work, 2025 to 2026.
Get this every Wednesday
Free every Wednesday, a five-minute read. Unsubscribe any time.